{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:16:39Z","timestamp":1783149399985,"version":"3.54.6"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Familial hypobetalipoproteinemia (FHBL) is an autosomal semi-dominant disorder usually caused by variants in the <jats:italic>APOB<\/jats:italic> gene that frequently interferes with protein length. Clinical manifestations include malabsorption, non-alcoholic fatty liver disease, low levels of lipid-soluble vitamins, and neurological, endocrine, and hematological dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genomic DNA was isolated from the blood samples of the pediatric patient with hypocholesterolemia and his parents and brother. Next-generation sequencing (NGS) was performed, and an expanded dyslipidemia panel was employed for genetic analysis. In addition, a systematic review of the literature on FHBL heterozygous patients was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>Genetic investigation revealed the presence of a heterozygous variant in the <jats:italic>APOB<\/jats:italic> (NM_000384.3) gene c.6624dup[=], which changes the open reading frame and leads to early termination of translation into the p.Leu2209IlefsTer5 protein (NP_000375.3). The identified variant was not previously reported. Familial segregation analysis confirmed the variant in the mother of the subject, who also has a low level of low-density lipoprotein and non-alcoholic fatty liver disease. We have introduced therapy that includes limiting fats in the diet and adding lipid-soluble vitamins E, A, K, and D and calcium carbonate. We reported 35 individuals with <jats:italic>APOB<\/jats:italic> gene variations linked to FHBL in the systematic review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have identified a novel pathogenic variant in the <jats:italic>APOB<\/jats:italic> gene causing FHBL in pediatric patients with hypocholesterolemia and fatty liver disease. This case illustrates the importance of genetic testing for dyslipidemias in patients with significant decreases in plasma cholesterol as we can avoid damaging neurological and ophthalmological effects by sufficient vitamin supplementation and regular follow-ups.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1106441","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:22:09Z","timestamp":1686630129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-alcoholic fatty liver disease in a pediatric patient with heterozygous familial hypobetalipoproteinemia due to a novel APOB variant: a case report and systematic literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Neza","family":"Molk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Bitenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Urlep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Zerjav Tansek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bertok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Trebusak Podkrajsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursa","family":"Sustar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jernej","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marusa","family":"Debeljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-12-387025-4.00004-2","article-title":"Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum","volume":"54","author":"Tarugi","year":"2011","journal-title":"Adv Clin Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/157016111794519354","article-title":"Hypocholesterolemia","volume":"9","author":"Moutzouri","year":"2011","journal-title":"Curr Vasc Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2015\/hc.v15i1.891","article-title":"Hypocholesterolemia: a blessing or a problem?","volume":"15","author":"Yalouris","year":"2020","journal-title":"Hosp Chronicles."},{"key":"B4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","article-title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","volume":"16","author":"Bredefeld","year":"2022","journal-title":"J Clin Lipidol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/ATVBAHA.112.301101","article-title":"A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia","volume":"33","author":"Cefal\u00f9","year":"2013","journal-title":"Arterioscl Thromb Vasc Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/17460875.2.6.615","article-title":"Genetics of familial hypobetalipoproteinemia","volume":"2","author":"Tarugi","year":"2007","journal-title":"Fut Lipidol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","article-title":"Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia","volume":"61","author":"Di Filippo","year":"2014","journal-title":"J Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia","volume":"25","author":"Welty","year":"2014","journal-title":"Curr Opin Lipidol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1053\/j.gastro.2020.11.040","article-title":"New classification and management of abetalipoproteinemia and related disorders","volume":"160","author":"Bredefeld","year":"2021","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MOL.0000000000000663","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease","volume":"31","author":"Welty","year":"2020","journal-title":"Curr Opin Lipidol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"W545","DOI":"10.1093\/nar\/gky471","article-title":"VarAFT: A variant annotation and filtration system for human next generation sequencing data","volume":"46","author":"Desvignes","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","article-title":"The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting","volume":"139","author":"Stenson","year":"2020","journal-title":"Hum Genet"},{"key":"B14","unstructured":"The Future of Genomic Medicine\n            GenooxF\n          2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2169\/internalmedicine.3737-19","article-title":"A healthy family of familial hypobetalipoproteinemia caused by a protein-truncating variant in the PCSK9 gene","volume":"59","author":"Tada","year":"2020","journal-title":"Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1172\/JCI113026","article-title":"Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipop","volume":"79","author":"Young","year":"1987","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(87)90510-1","article-title":"A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine","volume":"50","author":"Powell","year":"1987","journal-title":"Cell."},{"key":"B18","volume-title":"Clinical Lipidology: A Companion to Braunwald's Heart Disease","author":"Fazio","year":"2009"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1373\/clinchem.2004.038026","article-title":"Lipid disorders and mutations in the APOB gene","volume":"50","author":"Whitfield","year":"2004","journal-title":"Clin Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"11480","DOI":"10.3390\/ijms231911480","article-title":"A new structural model of apolipoprotein b100 based on computational modeling and cross linking","volume":"23","author":"Jeiran","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1073\/pnas.0602213103","article-title":"Apolipoprotein B is conformationally flexible but anchored at a triolein\/water interface: a possible model for lipoprotein surfaces","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","article-title":"The APOBEC protein family: united by structure, divergent in function","volume":"41","author":"Salter","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"p. 1109","DOI":"10.1016\/B978-0-12-809954-4.00049-9","article-title":"Genetic regulation of intestinal lipid transport and metabolism","author":"Davidson","year":"2018","journal-title":"Physiology of the Gastrointestinal Tract (Sixth Edition)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jacl.2017.06.013","article-title":"Clinical and biochemical characteristics of individuals with low cholesterol syndromes: a comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia","volume":"11","author":"Di Costanzo","year":"2017","journal-title":"J Clin Lipidol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/10408360500295113","article-title":"Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism","volume":"42","author":"Hooper","year":"2005","journal-title":"Crit Rev Clin Lab Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jacl.2020.12.010","article-title":"Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD","volume":"15","author":"Vilar-Gomez","year":"2021","journal-title":"J Clin Lipidol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gene.2013.08.049","article-title":"Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene","volume":"531","author":"Mart\u00edn-Morales","year":"2013","journal-title":"Gene."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00018-005-4473-0","article-title":"Familial hypobetalipoproteinemia: genetics and metabolism","volume":"62","author":"Schonfeld","year":"2005","journal-title":"Cell Mol Life Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.atherosclerosis.2007.05.003","article-title":"Molecular diagnosis of hypobetalipoproteinemia: an ENID review","volume":"195","author":"Tarugi","year":"2007","journal-title":"Atherosclerosis."},{"key":"B30","unstructured":"RobinNH\n            MoranRT\n            Ala-KokkoL\n          Seattle, Seattle, WAUniversity of WashingtonStickler Syndrome1993"},{"key":"B31","volume-title":"APOB-Related Familial hypobetalipoproteinemia.","author":"Burnett","year":"1993"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","article-title":"Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations","volume":"29","author":"Gidding","year":"2022","journal-title":"Eur J Prev Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"936121","DOI":"10.3389\/fgene.2022.936121","article-title":"Early discovery of children with lysosomal acid lipase deficiency with the universal familial hypercholesterolemia screening program","volume":"13","author":"Sustar","year":"2022","journal-title":"Front Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.gim.2022.06.010","article-title":"Universal screening for familial hypercholesterolemia in 2 populations","volume":"24","author":"Sustar","year":"2022","journal-title":"Genet Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/eye.2001.167","article-title":"Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipo-proteinaemia patients","volume":"15","author":"Chowers","year":"2001","journal-title":"Eye."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1106441\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:22:15Z","timestamp":1686630135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1106441\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":36,"alternative-id":["10.3389\/fmed.2023.1106441"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1106441","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"article-number":"1106441"}}